RHÖN-KLINIKUM AG  / Key word(s): Share Buyback

09.09.2015 10:15

Dissemination of an Ad hoc announcement according to § 15 WpHG, transmitted
by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.



With the approval of the audit committee of the supervisory board, the
management board of RHÖN-KLINIKUM AG today resolved to make a public
repurchase offer pursuant to item 4 of the agenda of the annual general
meeting of 12 June 2014 for the repurchase of up to 7,108,824 shares
outside the stock exchange.

The offer price per share (excluding ancillary purchase costs) paid by the
Company amounts to EUR 25.54. The offer price includes a premium of 7% on
the reference stock quote of EUR 23.8733 which is the average stock market
price at the Frankfurt Stock Exchange on the last three trading days before
the publication of the Repurchase Offer.

The period for the acceptance of the repurchase offer of the Company
commences on 11 September 2015, 0:00 hrs. (Central European Summer Time),
and ends, unless prolonged, on 8 October 2015, 24:00 hrs. (Central European
Summer Time).

The tender ratio for this repurchase offer is 31:3, the ownership of 31
shares thus entitles a shareholder to accept the repurchase offer for 3
shares. The shareholders shall be entitled to corresponding tender rights,
in each case with one share containing one tender right and 31 tender
rights being required to accept the repurchase offer for 3 shares.

To the extent shareholders should wish not to participate in the share
repurchase, they can sell their tender rights. Likewise, shareholders may
purchase additional tender rights if they would like to tender more shares.

The tender rights will be admitted to trading on the regulated market of
the Frankfurt Stock Exchange with simultaneous admission to the sub area
with additional post-admission obligations (Prime Standard) and the
regulated market of the Munich Stock Exchange and be tradable there dated
11 September 2015 until two banking days before the end of the acceptance
period. An off-market transfer of the tender rights is also permissible and
possible.

Baader Bank AG will be the financial institution accompanying the share
repurchase.

According to the resolution of the annual general meeting, repurchased
shares may only be used by the Company for the purpose of redemption.

Further details on the public repurchase offer can be found in the offer
document of the Company which will be published in the Federal Gazette
(www.bundesanzeiger.de) and in the German and the English language together
with additional information on the website of the Company (German version:
www.rhoen-klinikum-ag.com/aktie; English version:
www.rhoen-klinikum-ag.com/share).

Contact:

Dr. Kai G. Klinger
Head of Investor Relations
RHÖN-KLINIKUM AG
Schlossplatz 1
97616 Bad Neustadt a. d. Saale
Telefon: +49 (0) 9771 65-1318
Telefax: +49 (0) 9771 99-1736
E-Mail: ir@rhoen-klinikum-ag.com

Achim Struchholz
Corporate Communications
RHÖN-KLINIKUM AG
Schlossplatz 1
97616 Bad Neustadt a. d. Saale
Telefon: +49 (0) 9771 65-1327
Telefax: +49 (0) 9771 65-1820
E-Mail: kommunikation@rhoen-klinikum-ag.com 


09.09.2015 The DGAP Distribution Services include Regulatory Announcements,
Financial/Corporate News and Press Releases.
Media archive at www.dgap-medientreff.de and www.dgap.de


 
Language:     English
Company:      RHÖN-KLINIKUM AG
              Schlossplatz 1
              97616 Bad Neustadt a.d.Saale
              Germany
Phone:        +49 (0)9771 - 65-0
Fax:          +49 (0)9771 - 97 467
E-mail:       rka@rhoen-klinikum-ag.com
Internet:     www.rhoen-klinikum-ag.com
ISIN:         DE0007042301
WKN:          704230
Indices:      MDAX
Listed:       Regulated Market in Frankfurt (Prime Standard), Munich;
              Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg,
              Stuttgart
 
End of Announcement                             DGAP News-Service